Ngā hua rapu kaituhi :: APM

1

COVID-19 in cancer patients: risk, clinical features, and management mā Cuiwei Liu, Yanxia Zhao, Derick Okwan‐Duodu, Reva Basho, Xiaojiang Cui

I whakaputaina 2020

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Neoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial mā Heather L. McArthur, J.H.S. Leal, David B. Page, Aditya Bardia, Laura M. Spring, Christina DiLauro Abaya, Reva Basho, Lindsey Ristow, Hannah Coleman, Stephen L. Shiao, Simon Knott, Mourad Tighiouart, Farnaz Dadmanesh, Sunil Verma, A. E. Giuliano

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer mā Reva Basho, Clinton Yam, Michael Z. Gilcrease, Rashmi K. Murthy, Thorunn Helgason, Daniel D. Karp, Funda Meric‐Bernstam, Kenneth R. Hess, Vicente Valero, Constance T. Albarracin, Jennifer K. Litton, Mariana Chávez‐MacGregor, David S. Hong, Razelle Kurzrock, Gabriel N. Hortobágyi, Filip Janků, Stacy L. Moulder

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer mā Funda Meric‐Bernstam, Xiaofeng Zheng, Maryam Shariati, Senthil Damodaran, Chetna Wathoo, Lauren Brusco, Mehmet Demirhan, Coya Tapia, Agda Karina Eterovic, Reva Basho, Naoto T. Ueno, Filip Janků, Ayşegül A. Şahin, Jordi Rodón, Russell Broaddus, Tae-Beom Kim, John Mendelsohn, Kenna Shaw, Debu Tripathy, Gordon B. Mills, Ken Chen

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Clinical outcomes based on multigene profiling in metastatic breast cancer patients. mā Reva Basho, Débora De Melo Gagliato, Naoto T. Ueno, Ricardo H. Álvarez, Chetna Wathoo, Huiqin Chen, Caimiao Wei, Ayşegül A. Şahin, Sinchita Roy‐Chowdhuri, Stacy L. Moulder, Mariana Chavez-Mac Gregor, Jennifer K. Litton, Vicente Valero, Rajyalakshmi Luthra, Kenna Shaw, John Mendelsohn, Gordon B. Mills, Debu Tripathy, Funda Meric‐Bernstam

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Evaluating the impact of age on immune checkpoint therapy biomarkers mā Rossin Erbe, Zheyu Wang, Sharon Wu, Joanne Xiu, Neeha Zaidi, Jennifer La, David Tuck, Nathanael R. Fillmore, Nicolás A. Giraldo, Michael J. Topper, Stephen B. Baylin, Marc E. Lippman, Claudine Isaacs, Reva Basho, Ilya G. Serebriiskii, Heinz‐Josef Lenz, Igor Astsaturov, John L. Marshall, Josephine A. Taverna, Jerry Lee, Elizabeth M. Jaffee, Evanthia T. Roussos Torres, Ashani T. Weeraratna, Hariharan Easwaran, Elana J. Fertig

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP mā Jennifer K. Litton, Meredith M. Regan, Lajos Pusztai, Hope S. Rugo, Sara M. Tolaney, Elizabeth Garrett‐Mayer, Laleh Amiri‐Kordestani, Reva Basho, Ana F. Best, Jean-François Boileau, Carsten Denkert, Jared C. Foster, Nadia Harbeck, Heather A. Jacene, Tari A. King, Ginny Mason, Ciara C. O’Sullivan, Tatiana M. Prowell, Andrea L. Richardson, Karla A. Sepulveda, Mary Lou Smith, Judy A. Tjoe, Gulisa Turashvili, Wendy A. Woodward, Lynn Pearson Butler, Elena I. Schwartz, Larissa A. Korde

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: